Medical management of fibroids.
作者信息
Baird D T, West C P
机构信息
Department of Obstetrics and Gynaecology, University of Edinburgh.
出版信息
Br Med J (Clin Res Ed). 1988 Jun 18;296(6638):1684-5. doi: 10.1136/bmj.296.6638.1684.
Abstract
摘要
相似文献
1
Medical management of fibroids.子宫肌瘤的医学管理。
Br Med J (Clin Res Ed). 1988 Jun 18;296(6638):1684-5. doi: 10.1136/bmj.296.6638.1684.
2
Gonadotropin-releasing hormone agonists: utilization before hysterectomy.促性腺激素释放激素激动剂：子宫切除术前的应用
Clin Obstet Gynecol. 1993 Sep;36(3):642-9. doi: 10.1097/00003081-199309000-00020.
3
Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.子宫肌瘤的治疗：促性腺激素释放激素激动剂的当前研究结果
Am J Obstet Gynecol. 1992 Feb;166(2):746-51. doi: 10.1016/0002-9378(92)91707-h.
4
Depot GnRH analog treatment of uterine fibroids.长效GnRH类似物治疗子宫肌瘤。
Int J Gynaecol Obstet. 1993 Nov;43(2):199-201. doi: 10.1016/0020-7292(93)90333-r.
5
Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
Fertil Steril. 1988 Mar;49(3):538-41.
6
GnRH analogues in the treatment of uterine fibroids.促性腺激素释放激素类似物在子宫肌瘤治疗中的应用
Hum Reprod. 1996 Nov;11 Suppl 3:33-41. doi: 10.1093/humrep/11.suppl_3.33.
7
Mechanism of LHRH analogue action in uterine fibroids.
Horm Res. 1989;32 Suppl 1:150-3. doi: 10.1159/000181332.
8
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
Am J Obstet Gynecol. 1983 Nov 15;147(6):726-7. doi: 10.1016/0002-9378(83)90463-5.
9
Clinical experience in the treatment of fibroids with leuprolide and other GnRH agonists.使用亮丙瑞林及其他促性腺激素释放激素激动剂治疗子宫肌瘤的临床经验。
Obstet Gynecol Surv. 1989 May;44(5):311-3. doi: 10.1097/00006254-198905000-00005.
10
Uterine fibroids: medical treatment or surgery?子宫肌瘤：药物治疗还是手术治疗？
Lancet. 1986 Nov 22;2(8517):1197. doi: 10.1016/s0140-6736(86)92204-x.
引用本文的文献
1
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.戈舍瑞林。对其药效学和药代动力学特性以及在性激素相关病症中的临床应用的综述。
Drugs. 1991 Feb;41(2):254-88. doi: 10.2165/00003495-199141020-00008.
本文引用的文献
1
On the origin and development of uterine fibroids.论子宫肌瘤的起源与发展
Am J Obstet Gynecol. 1955 Oct;70(4):720-40. doi: 10.1016/s0002-9378(16)37829-2.
2
Uterine leiomyomata: etiology, symptomatology, and management.子宫平滑肌瘤：病因、症状及治疗
Fertil Steril. 1981 Oct;36(4):433-45. doi: 10.1016/s0015-0282(16)45789-4.
3
Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report.
Fertil Steril. 1984 Oct;42(4):644-6. doi: 10.1016/s0015-0282(16)48152-5.
4
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
Am J Obstet Gynecol. 1983 Nov 15;147(6):726-7. doi: 10.1016/0002-9378(83)90463-5.
5
Binding sites for epidermal growth factor in human uterine tissues and leiomyomas.人子宫组织和平滑肌瘤中表皮生长因子的结合位点。
J Clin Endocrinol Metab. 1984 May;58(5):880-4. doi: 10.1210/jcem-58-5-880.
6
Induction of degenerative changes in uterine myomas by high-dosage progestin therapy.高剂量孕激素疗法诱导子宫肌瘤发生退行性变
Am J Obstet Gynecol. 1966 Dec 15;96(8):1078-87. doi: 10.1016/0002-9378(66)90516-3.
7
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.子宫肌瘤的风险因素：口服避孕药与之相关的风险降低。
Br Med J (Clin Res Ed). 1986 Aug 9;293(6543):359-62. doi: 10.1136/bmj.293.6543.359.
8
Regression of uterine leiomyomas after treatment with gestrinone, an antiestrogen, antiprogesterone.
Am J Obstet Gynecol. 1986 Oct;155(4):761-7. doi: 10.1016/s0002-9378(86)80016-3.
9
Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
Fertil Steril. 1987 Oct;48(4):560-4.
10
Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.促黄体生成素释放激素激动剂类似物所致性腺功能减退：对绝经前女性骨密度的影响
Br Med J (Clin Res Ed). 1987 Jun 13;294(6586):1523-4. doi: 10.1136/bmj.294.6586.1523.
Zotero 插件